Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTSA | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | XKR4 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | GLG1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SVIL | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | NAA35 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | FICD | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | SFT2D3 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | ACTR3 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ACOT4 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RPL32 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |